ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.1473
-0.03%
Brent Oil
85.665
-0.27%
Bitcoin
60,530.38
-0.12%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Mind Medicine MindMed Inc (MNMD)

  7. Mind Medicine MindMed Inc (MNMD) Noticias

MNMD Mind Medicine MindMed Inc

9.24
0.21 (2.33%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mind Medicine MindMed Inc MNMD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.21 2.33% 9.24 18:38:24
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.01 8.81 9.55 9.52 9.03
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:00BWMindMed to Present at Upcoming May Medical Conferences
02/4/202406:00BWMindMed to Present at Upcoming April Medical Conferences
01/4/202416:00BWMindMed Announces Voluntary Delisting from Cboe Canada
11/3/202407:32EDGAR2Form 8-K - Current report
11/3/202406:00BWMindMed to Participate in the Leerink Partners 2024 Global..
07/3/202407:19EDGAR2Form 8-K - Current report
07/3/202406:13BWMind Medicine (MindMed) Inc. Announces Pricing of..
07/3/202406:09EDGAR2Form S-3MEF - Registration adding securities to prior Form..
07/3/202405:56EDGAR2Form 8-K - Current report
07/3/202405:00BWMindMed Receives FDA Breakthrough Therapy Designation and..
01/3/202412:56EDGAR2Form 144 - Report of proposed sale of securities
01/3/202408:00BWMindMed to Host Conference Call and Webcast to Discuss Data..
29/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202406:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202406:15EDGAR2Form 8-K - Current report
28/2/202406:05BWMindMed Reports 2023 Financial Results and Business Updates
22/2/202406:00BWMindMed to Host Conference Call and Webcast to Discuss 2023..
07/2/202406:00BWMindMed to Participate in the 34th Annual Oppenheimer..
08/1/202407:00EDGAR2Form 8-K - Current report
08/1/202406:45BWMindMed Announces Business Update and Anticipated Milestones..
26/12/202315:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202315:24EDGAR2Form 144 - Report of proposed sale of securities
14/12/202306:57EDGAR2Form 8-K - Current report
14/12/202306:30BWMindMed Announces Positive Topline Results from Phase 2b..
02/11/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:15EDGAR2Form 8-K - Current report
02/11/202315:01BWMindMed Reports Third Quarter 2023 Financial Results and..
26/10/202306:30BWMindMed to Host Conference Call and Webcast to Discuss Third..
24/10/202306:30BWMindMed Completes Enrollment of Phase 2a Trial of MM-120 in..
03/10/202306:30BWMindMed to Present Data on the Preclinical Activity of..
25/9/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202320:02EDGAR2Form 144 - Report of proposed sale of securities
25/9/202320:01EDGAR2Form 144 - Report of proposed sale of securities
25/9/202320:01EDGAR2Form 144 - Report of proposed sale of securities
15/9/202316:27EDGAR2Form 8-K/A - Current report: [Amend]
15/9/202316:23EDGAR2Form 8-K/A - Current report: [Amend]
14/9/202306:30BWMindMed to Participate in the TD Cowen 3rd Annual Novel..
12/9/202306:30BWMindMed Completes Enrollment of Phase 2b Trial of MM-120 in..
28/8/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202309:35EDGAR2Form 144 - Report of proposed sale of securities
28/8/202308:16EDGAR2Form 144 - Report of proposed sale of securities
28/8/202306:30BWMindMed to Participate at September Investor Conferences
14/8/202307:31EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
MNMD
Mind Medicine MindMed
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados